agapeatpgroup.com (ATPC) - Koefisien utang jangka dawa marang modal

Agape ATP - logo grafis emiten ATPC

Agape ATP Corporation (ATPC) relies on a network of Asian wellness centers and direct product sales, which is corroborated by the long-term debt financial leverage ratio. The 0.00 level indicates the status of the parameter as the company establishes barriers to entry for competitors through its ecosystem of clinics and regulatory standards. Simultaneously, the business is developing IT services for predictive metabolism analysis, integrating digital transformation into preventive medicine.

agapeatpgroup.com (ATPC): Utang jangka dawa marang ekuitas saka 21.02.2024 nganti 31.10.2026
Produk mawa merek Agape ATP Corp

This ratio measures the proportion of debt with a maturity exceeding one year relative to equity. It allows an investor to assess financial stability and the extent of the business's dependence on external financing. The trend of the long-term debt-to-equity ratio reflects the balance between bankruptcy risks and expansion rates. For Agape ATP Corporation (ATPC), this indicator is critical during the transition from capital-intensive clinics to scalable e-commerce. A reduction in the debt load would confirm the effectiveness of the digital transformation and the optimization of operating expenses.

Analisis perusahaan pesaing

Ascendis Pharma AS - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal MDGL|CORT (Corcept Therapeutics Corp) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal RYTM (Rhythm Pharmaceuticals)|Utang jangka dawa marang modal akerotx.com AKRO|MTSR - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal MLTX (MoonLake Immunotherapeutics AG)|Crinetics Pharma (CRNX) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas NewAmsterdam Pharma Corp|SLNO (Soleno Therapeutics) - Utang jangka dawa marang modal|Utang jangka dawa marang modal amicusrx.com|Rasio utang jangka dawa marang ekuitas ETNB (89bio)|AGIO (Agios) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Structure Pharma GPCR|MDXG - Rasio utang jangka dawa marang ekuitas|Rezolute, Inc. - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal lexpharma.com|MBX (MBX Biosciences) - Rasio utang jangka dawa marang ekuitas|ALT: Rasio silihan jangka dawa marang modal|AARD (Aardvark Therapeutics Corp) - Utang jangka dawa marang modal|Utang jangka dawa marang modal Sagimet Biosciences Inc|Utang jangka dawa marang modal BIOA|Utang jangka dawa marang ekuitas BMEA (biomeafusion.com)|Utang jangka dawa marang ekuitas Quince Therapeutics, Inc. QNCX|Fractyl Health Inc. (GUTS) - Kewajiban jangka dawa marang modal|VTVT - Utang jangka dawa marang ekuitas|PLUR: Utang jangka dawa marang ekuitas|SYBX: Utang jangka dawa marang modal|LPCN - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Matinas BioPharma Holdings, Inc.|Spruce Biosciences Inc. (SPRB) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Galecto Corp (GLTO)|Rasio utang jangka dawa marang ekuitas Carmell Therapeutics CTCX|Utang jangka dawa marang modal LUMO (Lumos Pharma, Inc.)|Utang jangka dawa marang modal organovo.com ONVO|Radius Recycling - Utang jangka dawa marang modal